Crispr Therapeutics AG

CRSP·NASDAQ·$51.59Share Price as of 11/2·$5BMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/03/26 10-QQ1 ended 03/31/2605/04/26 10-KFY 202502/12/26 10-QQ3 ended 09/30/2511/10/25 10-QQ2 ended 06/30/2508/04/25

Disclosures

8-KCurrent report10/19/26 8-KCurrent report08/03/26 8-KCurrent report06/04/26 8-KCurrent report05/04/26 8-KCurrent report03/16/26

Prospectuses and Registrations

S-8Registration of securities for employees06/05/26 424B5Prospectus supplement10/15/25 424B5Prospectus supplement05/19/25 S-3ASRAutomatic shelf registration08/05/24 S-8Registration of securities for employees08/05/24

Proxies

DEF 14ADefinitive proxy04/21/26 DEFA14AAdditional proxy materials04/21/26 PRE 14APreliminary proxy04/02/26 DEF 14ADefinitive proxy04/16/25 DEFA14AAdditional proxy materials04/16/25

Ownership

Form 4Insider transaction10/28/26 Form 4Insider transaction10/28/26 Form 4Insider transaction10/28/26 Form 4Insider transaction10/28/26 Form 3Initial insider ownership10/21/26

Other

ARSAnnual report to shareholders04/21/26 ARSAnnual report to shareholders04/16/25 ARSAnnual report to shareholders04/09/24 ARSAnnual report to shareholders04/26/23 UPLOADLetter from the SEC07/13/22